NO145383C - Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.

Info

Publication number
NO145383C
NO145383C NO754313A NO754313A NO145383C NO 145383 C NO145383 C NO 145383C NO 754313 A NO754313 A NO 754313A NO 754313 A NO754313 A NO 754313A NO 145383 C NO145383 C NO 145383C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
active substituted
analogue procedure
indols
Prior art date
Application number
NO754313A
Other languages
English (en)
Norwegian (no)
Other versions
NO754313L (it
NO145383B (no
Inventor
Michael Zelesko
David Mccomsey
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NO754313L publication Critical patent/NO754313L/no
Publication of NO145383B publication Critical patent/NO145383B/no
Publication of NO145383C publication Critical patent/NO145383C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO754313A 1974-12-30 1975-12-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler. NO145383C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53761274A 1974-12-30 1974-12-30
US63179875A 1975-11-13 1975-11-13

Publications (3)

Publication Number Publication Date
NO754313L NO754313L (it) 1976-07-01
NO145383B NO145383B (no) 1981-11-30
NO145383C true NO145383C (no) 1982-03-10

Family

ID=27065555

Family Applications (1)

Application Number Title Priority Date Filing Date
NO754313A NO145383C (no) 1974-12-30 1975-12-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.

Country Status (27)

Country Link
JP (1) JPS51131872A (it)
AR (1) AR219052A1 (it)
AT (1) AT356648B (it)
AU (1) AU505215B2 (it)
CA (1) CA1065874A (it)
CH (1) CH622516A5 (it)
DD (1) DD125781A5 (it)
DE (1) DE2559211A1 (it)
DK (1) DK580175A (it)
ES (1) ES443935A1 (it)
FI (1) FI64590C (it)
FR (2) FR2296413A1 (it)
GB (1) GB1527510A (it)
HU (2) HU174948B (it)
IE (1) IE42390B1 (it)
IL (1) IL48756A (it)
IN (1) IN142735B (it)
IT (1) IT1052654B (it)
NL (1) NL7515100A (it)
NO (1) NO145383C (it)
NZ (1) NZ179580A (it)
PH (1) PH12328A (it)
PL (1) PL99353B1 (it)
RO (1) RO69196A (it)
SE (1) SE422210B (it)
SU (1) SU667132A3 (it)
YU (1) YU332275A (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595056A (en) * 1976-10-12 1981-08-05 Wellcome Found Pharmaceutical combination
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
US4558048A (en) * 1984-04-06 1985-12-10 Pfizer Inc. Method of treating diarrhoea using indole compounds
US6639109B1 (en) 1999-09-28 2003-10-28 Nihon Nohyaku Co., Ltd. Process for production of thioalkylamine derivatives
MXPA05004929A (es) 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
WO2007020653A1 (en) * 2005-08-12 2007-02-22 Suven Life Sciences Limited Thioether derivatives as functional 5-ht6 ligands

Also Published As

Publication number Publication date
SE422210B (sv) 1982-02-22
HU174948B (hu) 1980-04-28
CA1065874A (en) 1979-11-06
YU332275A (en) 1983-02-28
FI64590C (fi) 1983-12-12
FR2296413B1 (it) 1980-06-27
AR219052A1 (es) 1980-07-31
FR2315921B1 (it) 1979-09-28
GB1527510A (en) 1978-10-04
RO69196A (ro) 1980-08-15
HU174949B (hu) 1980-04-28
IL48756A (en) 1979-03-12
IT1052654B (it) 1981-07-20
FI753669A (it) 1976-07-01
JPS51131872A (en) 1976-11-16
PH12328A (en) 1979-01-16
NZ179580A (en) 1978-04-03
DK580175A (da) 1976-07-01
PL99353B1 (pl) 1978-07-31
DD125781A5 (it) 1977-05-18
NL7515100A (nl) 1976-07-02
AU8791675A (en) 1977-07-07
AT356648B (de) 1980-05-12
FI64590B (fi) 1983-08-31
AU505215B2 (en) 1979-11-15
SE7514458L (sv) 1976-07-01
ES443935A1 (es) 1977-08-16
CH622516A5 (en) 1981-04-15
FR2315921A1 (fr) 1977-01-28
NO754313L (it) 1976-07-01
IE42390L (en) 1976-06-30
IN142735B (it) 1977-08-20
IL48756A0 (en) 1976-02-29
IE42390B1 (en) 1980-07-30
FR2296413A1 (fr) 1976-07-30
NO145383B (no) 1981-11-30
ATA986075A (de) 1979-10-15
SU667132A3 (ru) 1979-06-05
DE2559211A1 (de) 1976-07-08

Similar Documents

Publication Publication Date Title
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO157933C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO141717C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive triazolopyridaziner
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO148375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser
NO144926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO144773C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive aminer.
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO144928C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder